RU95105464ARU95105464/14ARU95105464ARU95105464ARU 95105464 ARU95105464 ARU 95105464ARU 95105464/14 ARU95105464/14 ARU 95105464/14ARU 95105464 ARU95105464 ARU 95105464ARU 95105464 ARU95105464 ARU 95105464A
Всероссийский научно-исследовательский институт мясной промышленности
А.Д. Неклюдов
Е.А. Евстафьева
А.Б. Лисицын
М.И. Бабурина
В.Д. Кузнецов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Всероссийский научно-исследовательский институт мясной промышленности, А.Д. Неклюдов, Е.А. Евстафьева, А.Б. Лисицын, М.И. Бабурина, В.Д. КузнецовfiledCriticalВсероссийский научно-исследовательский институт мясной промышленности
Priority to RU95105464ApriorityCriticalpatent/RU2108102C1/en
Publication of RU95105464ApublicationCriticalpatent/RU95105464A/en
Application grantedgrantedCritical
Publication of RU2108102C1publicationCriticalpatent/RU2108102C1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Coloring Foods And Improving Nutritive Qualities
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
FIELD: medicine, hematology. SUBSTANCE: antianemic agent has the following components, wt.-%: hemin 1.7-2.0; blood proteins 15-20, and carboxymethylcellulose, the balance. Agent can be used in food industry, medicine and veterinary science as curative-prophylaxis preparation in diseases associated with hemogenesis. EFFECT: enhanced effectiveness of agent.
Claims (1)
Изобретение относится к производству лечебно-профилактических препаратов при заболеваниях, связанных с кроветворением и может быть использовано в пищевой промышленности, медицине и ветеринарии. Сущность изобретения: противоанемическое средство содержит гемин, белки крови и карбоксиметилцеллюлозу при соотношении мас.%: гемин 1,7 - 2,0%, белки крови 15 - 20%, карбоксиметилцеллюлоза остальное.The invention relates to the production of therapeutic drugs for diseases associated with hematopoiesis and can be used in the food industry, medicine and veterinary medicine. The inventive anti-anemic agent contains hemin, blood proteins and carboxymethyl cellulose with a ratio of wt.%: Hemin 1.7 - 2.0%, blood proteins 15 - 20%, carboxymethyl cellulose and the rest.
NEW DERIVATIVES OF THERAPEUTICALLY ACTIVE PEPTIDES IN THE BLOOD COAGULATION CHAIN, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.